Get the Stockscreener App
3.43
9.94%
0.31
After Hours:
3.36
-0.07
-2.04%
Medicus Pharma Ltd Stock (MDCX) Forecast
The Medicus Pharma Ltd (MDCX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $42.22, representing a +1,131% increase from the current price of $3.43. The highest analyst price target is $70.22, and the lowest is $14.22.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MDCX Price Target
Average 195.81
(+5,609% Upside)
Is Medicus Pharma Ltd (MDCX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 20.82 | Buy |
| STOCH(9,6) | 5.7738 | Buy |
| STOCHRSI(14) | 16.35 | Buy |
| MACD(12,26) | -1.7894 | Sell |
| ADX(14) | 32.75 | Sell |
| William %R | -90.96 | Buy |
| CCI(14) | -134.66 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.548
Sell
|
4.9765
Sell
|
| MA20 |
6.7805
Sell
|
6.3973
Sell
|
| MA50 |
10.01
Sell
|
9.5474
Sell
|
| MA100 |
14.19
Sell
|
15.27
Sell
|
| MA200 |
26.92
Sell
|
34.35
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MDCX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on MDCX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 20.82 indicates that MDCX is oversold. This indicates that MDCX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 5.7738 indicates that MDCX is oversold. This indicates that MDCX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.35 indicates that MDCX is oversold. This suggests that MDCX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.75 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -134.66 indicates that MDCX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MDCX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Medicus Pharma Ltd financial reports and earnings history, Medicus Pharma Ltd (MDCX) stock could reach $34.81 by 2030, $374.07 by 2040 and $194.74 by 2050. See the projected annual prices until 2050 of the Medicus Pharma Ltd stock below:
- Medicus Pharma Ltd (MDCX) is expected to reach an average price of $44.63 in 2035, with a high prediction of $52.27 and a low estimate of $46.67. This indicates an $1,201% rise from the last recorded price of $3.43.
- Medicus Pharma Ltd (MDCX) stock is projected to chart a bullish course in 2040, with an average price target of $351.22, representing an $10,140% surge from its current level. The forecast ranges from a conservative $367.72 to a sky-high $374.07.
- Our analysts predict Medicus Pharma Ltd (MDCX) to jump 8,955% by 2045, soaring from $316.32 to an average price of $310.60, potentially reaching $308.04. While $316.32 is the low estimate, the potential upside is significant.
- Medicus Pharma Ltd (MDCX) stock is expected to climb by 2050, reaching an average of $162.86, a $4,648% jump from its current level. However, a wide range of estimates exists, with high and low targets of $194.74 and $163.49, respectively, highlighting the market's uncertainty.
Medicus Pharma Ltd Stock (MDCX) Year by Year Forecast
Medicus Pharma Ltd Stock (MDCX) Price Forecast for 2026
The predicted value for Medicus Pharma Ltd (MDCX) in 2026 is set at an average of $43.94. Estimates vary from a peak of $85.00 to a trough of $2.88, indicating an +1,181% surge from the present price of $3.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $33.43 | $14.22 | $70.22 | +874.75% |
| December, 2026 | $58.14 | $23.74 | $65.14 | +1,595% |
Medicus Pharma Ltd Stock (MDCX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Medicus Pharma Ltd (MDCX) is $204.75, with a high forecast of $377.39 and a low forecast of $32.12. This indicates an +5,870% increase from the last price of $3.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $118.35 | $41.95 | $137.91 | +3,351% |
| February, 2027 | $87.48 | $41.76 | $168.65 | +2,450% |
| March, 2027 | $125.57 | $68.98 | $134.57 | +3,561% |
| April, 2027 | $158.28 | $106.88 | $178.78 | +4,515% |
| May, 2027 | $62.79 | $48.19 | $377.39 | +1,731% |
| June, 2027 | $105.00 | $48.15 | $115.50 | +2,961% |
| July, 2027 | $62.21 | $58.29 | $121.31 | +1,714% |
| August, 2027 | $40.23 | $32.12 | $72.52 | +1,073% |
| September, 2027 | $77.93 | $33.53 | $98.93 | +2,172% |
| October, 2027 | $67.64 | $57.04 | $83.84 | +1,872% |
| November, 2027 | $60.16 | $53.66 | $89.45 | +1,654% |
| December, 2027 | $41.36 | $36.36 | $68.56 | +1,106% |
Medicus Pharma Ltd Stock (MDCX) Price Forecast for 2028
In 2028, Medicus Pharma Ltd (MDCX) is projected to reach an average price of $33.02, with a high projection of $65.76 and a low estimate of $0.2807. This indicates an +862.69% rise from the last price of $3.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $30.38 | $26.57 | $44.67 | +785.61% |
| February, 2028 | $17.09 | $9.9557 | $35.68 | +398.13% |
| March, 2028 | $5.425 | $13.38 | $51.49 | +58.16% |
| April, 2028 | $7.1456 | $7.8976 | $7.168 | +108.33% |
| May, 2028 | $11.22 | $7.9933 | $11.18 | +227.08% |
| June, 2028 | $3.3246 | $7.7746 | $7.5769 | -3.07% |
| July, 2028 | $4.0521 | $0.9397 | $6.3471 | +18.14% |
| August, 2028 | $3.4464 | $0.8941 | $6.9167 | +0.48% |
| September, 2028 | $1.7457 | $0.2807 | $5.7534 | -49.10% |
| October, 2028 | $0.6824 | $0.6326 | $3.6377 | -80.11% |
| November, 2028 | $0.0183 | $0.4233 | $3.9217 | -99.47% |
| December, 2028 | $33.05 | $0.8995 | $65.76 | +863.58% |
Medicus Pharma Ltd Stock (MDCX) Price Forecast for 2029
The 2029 price forecast for Medicus Pharma Ltd Stock (MDCX) is $154.15 on average, with a high prediction of $307.78 and a low estimate of $0.5314. This represents an +4,394% increase from the previous price of $3.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $49.03 | $50.45 | $34.13 | +1,329% |
| February, 2029 | $38.11 | $42.11 | $23.42 | +1,011% |
| March, 2029 | $37.81 | $23.81 | $87.81 | +1,002% |
| April, 2029 | $32.33 | $3.6666 | $52.41 | +842.66% |
| May, 2029 | $50.25 | $12.44 | $69.25 | +1,365% |
| June, 2029 | $195.67 | $41.86 | $209.17 | +5,605% |
| July, 2029 | $8.306 | $6.9106 | $307.78 | +142.16% |
| August, 2029 | $25.11 | $9.508 | $58.11 | +632.15% |
| September, 2029 | $8.5314 | $0.5314 | $42.72 | +148.73% |
| October, 2029 | $17.95 | $17.05 | $11.04 | +423.19% |
| November, 2029 | $10.22 | $6.2234 | $45.37 | +198.06% |
| December, 2029 | $24.50 | $5.0781 | $39.89 | +614.19% |
Medicus Pharma Ltd Stock (MDCX) Price Forecast for 2030
Medicus Pharma Ltd Stock (MDCX) is expected to reach an average price of $20.76 in 2030, with a high forecast of $37.47 and a low forecast of $4.0554. This signifies an +505.29% surge from the last price of $3.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.92 | $4.0554 | $34.81 | +451.47% |
| February, 2030 | $6.4159 | $5.6247 | $24.62 | +87.05% |
| March, 2030 | $8.7473 | $4.8519 | $3.5434 | +155.02% |
| April, 2030 | $11.22 | $12.64 | $13.83 | +227.23% |
| May, 2030 | $38.36 | $16.12 | $36.62 | +1,018% |
| June, 2030 | $36.69 | $36.69 | $37.47 | +969.58% |
| July, 2030 | $32.61 | $36.86 | $37.47 | +850.82% |
| August, 2030 | $25.44 | $27.19 | $30.65 | +641.82% |
| September, 2030 | $14.11 | $14.91 | $23.59 | +311.26% |
| October, 2030 | $14.74 | $12.59 | $11.33 | +329.81% |
| November, 2030 | $9.1989 | $9.4039 | $10.41 | +168.19% |
| December, 2030 | $6.4405 | $6.5555 | $7.2042 | +87.77% |
1.05%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):